𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tuberin – A New Molecular Target in Alzheimer’s Disease?

✍ Scribed by Rosa Ferrando-Miguel; Margit Rosner; Angelika Freilinger; Gert Lubec; Markus Hengstschläger

Publisher
Springer
Year
2005
Tongue
English
Weight
287 KB
Volume
30
Category
Article
ISSN
0364-3190

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cdk5, a therapeutic target for Alzheimer
Cdk5, a therapeutic target for Alzheimer's disease?
✍ Li-Huei Tsai; Ming-Sum Lee; Jonathan Cruz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Alzheimer's disease (AD) represents the leading cause for senile dementia affecting more than 4 million people worldwide. AD patients display a triad of pathological features including brain atrophy caused by neuronal loss, h-amyloid plaque and neurofibrillary tangles. We previously show that Cyclin

Cholinergic abnormalities in Alzheimer's
Cholinergic abnormalities in Alzheimer's disease: are there new targets for drug development?
✍ Lisa R. Fodero; David H. Small 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

## Abstract Alzheimer's disease (AD) is a neurodegenerative disease characterized by cognitive impairment and behavioral changes. Cholinesterase inhibitors are currently the drugs of choice for the treatment of AD. However, alternatives to cholinesterase inhibitors such as muscarinic and nicotinic